Sunday, July 3, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

by Medical Finance
in Coronavirus
Study: Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Image Credit: CROCOTHERY/Shutterstock
9
SHARES
103
VIEWS
Share on FacebookShare on Twitter

In a study posted recently to the bioRxiv* preprint server, researchers determined the early immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) during mild coronavirus disease 2019 (COVID-19) in rhesus macaques.

Study: Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Image Credit: CROCOTHERY/ShutterstockStudy: Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Image Credit: CROCOTHERY/Shutterstock


In humans, COVID-19 manifests with a wide range of symptoms and clinical outcomes such as in asymptomatic cases where the viral infection is effectively controlled and severe cases with fatal infections due to organ failures. More research is required to unravel these differences in the immune response and functions of individual immune cell types between asymptomatic and severe COVID-19 cases.

Several studies have shown that in severe COVID-19, levels of pro-inflammatory cytokines are increased, type I interferon-γ (IFN-γ) response is deficient, and inflammasomes, monocytes/macrophages, and neutrophils are activated. Autopsy reports of COVID-19 patients have shown that extrapulmonary tissues lacked infiltrating immune cells despite the high viral presence. These observations underpin the need to understand the host immune response in the first few days of SARS-CoV-2 infection.

The study

In the present study, a team of researchers used rhesus macaques as models to elucidate 1) lung inflammation kinetics by using 18FDG (fluorodeoxyglucose) positron emission tomography/computed tomography (PET/CT ) imaging, 2) the innate immune response by scRNAseq (single-cell RNA sequencing), and 3) the SARS-CoV-2-specific T cell distribution in tissues by flow cytometry.

Findings

PET/CT imaging revealed heterogeneous inflammatory foci with increased 18FDG uptake and lesion density at 3 days post-infection (dpi) which resolved by 9 dpi. Nasal and throat swab samples showed that total genomic nucleocapsid (gN) and subgenomic nucleocapsid (sgN) RNA levels peaked at 1-2 dpi, and by 7-10 dpi their levels were undetectable. Viral RNA was found in bronchoalveolar lavage (BAL) at 4 dpi which was lost by 7-10 dpi and it was observed that plasma lacked viral RNA at all time points. Necropsy performed at 10 dpi for tissue analysis demonstrated the presence of SARS-CoV-2 gN RNA in all secondary lymphoid organs (SLO) and non-lymphoid tissues (NLT).

scRNAseq analysis was conducted on peripheral blood mononuclear cells (PBMCs) and BAL samples collected before infection and at 4, 7, and 10 dpi. No major changes in T/NK cell composition from PBMCs were detected, and at 4 dpi, naïve CD8 T cell levels dropped while memory CD4­­ T cells increased. Similarly, at 4 dpi in the myeloid cells, the CD14+ monocytes expressing PGTS2 declined with a corresponding increase in two inflammatory monocyte populations that had IFN responsive gene signatures.

In the BAL samples, distinct T cell and myeloid populations and further clustering of classified myeloid and T cells into 10 and 5 populations, respectively, were seen. At 4 dpi, a mixed population of CD8 and CD4 cells, with IFN responsive gene signatures, was observed which was cleared by 7 dpi. Consistent with the other findings, IFN-activated monocytes and macrophages in the BAL showed changes in population at 4 dpi and their numbers declined by 7 dpi.

The researchers observed a decline in B cells after infection, but a 2-3% increase in activated naïve B cells from PBMCs was noted at 4 and 7 dpi and the humoral responses were detectable by 10 dpi. The authors performed ex vivo restimulation with peptide pools from SARS-CoV-2 spike (S), nucleocapsid (N), and membrane (M) proteins, and multiple SARS-CoV-2 antigens found to be immunogenic in humans. The antigen-specific T cell response was more notable in BAL than in PBMC, and overall, the T cell responses were around 10-20 fold higher in the BAL than in PBMC.

Memory CD4 and CD8 cells were seen in all NLTs while antigen-specific CD4 and CD8 T cells were abundant in pulmonary tissues but were undetectable in many nasal turbinates, salivary glands, and tonsils.

Conclusions

The present study demonstrated that the SARS-CoV-2 replication kinetics and the immune response in rhesus macaques followed a typical pattern of acute viral infection. SARS-CoV-2 viral load peaked at 1-2 dpi and declined subsequently, while IFN-activated monocytes, macrophages, and dendritic cells in PBMC and BAL effectively acted in the early phase of infection in rhesus macaques.

The absence of antigen-specific T cells in the extrapulmonary mucosal tissues (salivary glands, tonsils, and nasal turbinates) during SARS-CoV infection was surprising; nevertheless, the authors proposed that the effector T cells could accumulate after 10 dpi and emphasized that further research into tissue distribution of effector T cells is needed.

Altogether, these findings indicate that SARS-CoV-2 replication is mostly suppressed before the antigen-specific T cell response is elicited and suggest that T cell activity could most likely be pronounced when the infection is not resolved by innate immune factors in moderate or severe COVID-19.

*Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens. Image Credit: Fit Ztudio/Shutterstock

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

by Medical Finance
July 3, 2022
0

Emergence of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (B.1.1.529) has startled the world. The...

Study: Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors. Image Credit: Kateryna Kon / Shutterstock.com

Neutralizing antibody levels to different SARS-CoV-2 epitopes fluctuate over time

by Medical Finance
July 3, 2022
0

The potential utility of neutralizing antibodies as anti-viral treatments have led many researchers to study the humoral immune response to...

Study: The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers. Image Credit: Marcos Homem / Shutterstock.com

Canadian study estimates incidence rate of reinfection in healthcare workers

by Medical Finance
July 3, 2022
0

According to the World Health Organization (WHO), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the causative agent coronavirus disease...

Bmal1 gene present in the striatum influences alcohol consumption in both male and female mice

New tool appears to accurately identify patients at risk of death from alcohol-associated hepatitis

by Medical Finance
July 3, 2022
0

Mayo Clinic researchers have developed a new scoring system to help health care professionals predict the 30-day mortality risk for...

Study: Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals. Image Credit: simona pilolla 2/Shutterstock

Study demonstrates associations between COVID-19 symptom presentation and antibody assay reactivity

by Medical Finance
July 3, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers tested convalescent sera from individuals who had recovered from...

Study: Identification of a conserved drug binding pocket in TMEM16 proteins. Image Credit: Irina Anosova/Shutterstock

Study reveals that 1PBC and niclosamide bind the same drug-binding pocket

by Medical Finance
July 3, 2022
0

In a recent preprint posted to Research Square* and under consideration at a Nature Portfolio Journal, researchers used cryo-electron microscopy...

Next Post
Study: Effect of Vaccination on Household Transmission of SARS-CoV-2 Delta VOC. Image Credit: TY Lim / Shutterstock.com

Danish household study shows COVID vaccinates reduce susceptibility and transmissibility

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles. Image Credit: NIAID
    Unique heightened aggregation of SARS-CoV-2 Delta variant spike pseudotyped particles
  • Study: researchers reviewed the material properties and administration routes that could successfully deliver a messenger ribonucleic acid (mRNA) therapeutic agent to its targeted site. Image Credit: thodonal88/Shutterstock
    Exploring strategies for successful delivery of messenger RNA therapeutics
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply